Skip to main content

Table 3 Reasons for discontinuation of tadalafil OaD treatment by age group

From: Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities

 

Number (%) of patients

 

Age ≤65 years N = 598

Age >65 years N = 180

Overall N = 778

Discontinued tadalafil OaDa

61 (100.0)

46 (100.0)

107 (100.0)

 Reasons

   

  Lack of efficacy (hardness of erection)

17 (27.9)

16 (34.4)

33 (30.8)

  Adverse event

10 (22.5)

12 (26.1)

22 (20.6)

  Cost of medication

11 (18.0)

5 (10.9)

16 (15.0)

  Didn’t want to take a pill every day

7 (11.0)

5 (10.9)

12 (11.2)

  Patient discontinued study

7 (11.5)

2 (4.3)

9 (8.4)

  Partner’s request

2 (3.3)

3 (6.5)

5 (4.7)

  Felt that medication controlled his sexual life

2 (4.2)

1 (2.2)

3 (2.8)

  Slow onset of action

2 (3.3)

1 (2.2)

3 (2.8)

  Lack of efficacy (duration of erection)

1 (1.6)

1 (2.2)

2 (1.9)

  Lack of confidence in medication

1 (1.6)

0

1 (0.9)

  Non-desired spontaneous erections

1 (1.6)

0

1 (0.9)

  1. N number of patients, OaD once a day
  2. aIncludes all patients with documented end date of tadalafil OaD treatment, irrespective if the patient completed or discontinued the study